These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 33369708

  • 1. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV.
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
    Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, Viktil E, Henriksen M, Hovde Ø, Huppertz-Hauss G, Høie O, Høivik ML, Monstad I, Solberg IC, Jahnsen J, Karlsen TH, Moum B, Vatn M, Negård A.
    Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
    [Abstract] [Full Text] [Related]

  • 3. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.
    Belle A, Laurent V, Pouillon L, Baumann C, Orry X, Lopez A, Rousseau H, Bronowicki JP, Peyrin-Biroulet L.
    Dig Liver Dis; 2018 Oct; 50(10):1012-1018. PubMed ID: 30076016
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M, Abedi SH, Malekpour H, Radinnia E, Jabbehdari S, Padashi M, Zali MR, Mohammad Alizadeh AH.
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [Abstract] [Full Text] [Related]

  • 5. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Catassi G, D'Arcangelo G, Norsa L, Bramuzzo M, Hojsak I, Kolho KL, Romano C, Gasparetto M, Di Giorgio A, Hussey S, Yerushalmy-Feler A, Turner D, Matar M, Weiss B, Karoliny A, Alvisi P, Tzivinikos C, Aloi M.
    Inflamm Bowel Dis; 2024 Oct 03; 30(10):1662-1669. PubMed ID: 37768032
    [Abstract] [Full Text] [Related]

  • 6. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J, Van Steenbergen W, Van Pelt J, Laleman W, Hoffman I, Geboes K, Vermeire S, Nevens F.
    Aliment Pharmacol Ther; 2016 Mar 03; 43(5):612-20. PubMed ID: 26748470
    [Abstract] [Full Text] [Related]

  • 7. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM, International PSC Study Group.
    Gastroenterology; 2017 Jun 03; 152(8):1975-1984.e8. PubMed ID: 28274849
    [Abstract] [Full Text] [Related]

  • 8. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP, Spanish GETECCU group (ENEIDA Project).
    J Crohns Colitis; 2019 Dec 10; 13(12):1492-1500. PubMed ID: 31063540
    [Abstract] [Full Text] [Related]

  • 9. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, Tuynman HA, Beuers U, Ponsioen CY.
    Inflamm Bowel Dis; 2012 Dec 10; 18(12):2270-6. PubMed ID: 22407885
    [Abstract] [Full Text] [Related]

  • 10. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W.
    United European Gastroenterol J; 2022 Mar 10; 10(2):212-224. PubMed ID: 35107865
    [Abstract] [Full Text] [Related]

  • 11. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP.
    J Crohns Colitis; 2014 Sep 10; 8(9):956-63. PubMed ID: 24559536
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
    Zhang Y, Gao X, He Z, Jia H, Chen M, Wang X, Hong L, Cui Y, Wan J.
    Liver Int; 2022 Aug 10; 42(8):1814-1822. PubMed ID: 35689520
    [Abstract] [Full Text] [Related]

  • 13. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I, Cazzagon N, Del Ross T, D'Incà R, Buja A, Floreani A.
    Eur J Gastroenterol Hepatol; 2016 May 10; 28(5):508-13. PubMed ID: 26872110
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.
    Liver Int; 2018 Mar 10; 38(3):532-541. PubMed ID: 28796371
    [Abstract] [Full Text] [Related]

  • 15. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O, Schrumpf E, Elgjo K.
    Semin Liver Dis; 1991 Feb 10; 11(1):31-9. PubMed ID: 2047887
    [Abstract] [Full Text] [Related]

  • 16. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM, Swiss IBD Cohort Study Group.
    Eur J Gastroenterol Hepatol; 2017 Jan 10; 29(1):91-97. PubMed ID: 27622999
    [Abstract] [Full Text] [Related]

  • 17. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E, Kosar Y, Ulker A, Dagli U, Alkim C, Sahin B.
    J Clin Gastroenterol; 2001 Oct 10; 33(4):299-301. PubMed ID: 11588543
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
    Culver EL, Bungay HK, Betts M, Forde C, Buchel O, Manganis C, Warren BF, Cummings FR, Keshav S, Travis SPL, Chapman RW.
    Liver Int; 2020 Nov 10; 40(11):2744-2757. PubMed ID: 32841490
    [Abstract] [Full Text] [Related]

  • 19. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME.
    Clin Rev Allergy Immunol; 2020 Feb 10; 58(1):134-149. PubMed ID: 31463807
    [Abstract] [Full Text] [Related]

  • 20. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
    Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arrivé L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS, IPSCSG.
    Eur Radiol; 2022 Feb 10; 32(2):923-937. PubMed ID: 34363134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.